Please BOOKMARK this site for future reference and be sure to visit our articles,
resources and
brochure pages.
The Consumer Law Page is regularly updated and is published by Alexander Hawes, LLP,
a law firm leading the legal profession in serving the public, consumers
and small businesses, individually and in class actions, in cases in which
corporate abuse, fraud, defective products and toxic chemicals have caused
personal injuries or damage to property. This site, along with its affiliate
site, Alexander Hawes, LLP,
averages thousands of visits per month. Thank you for your positive
response.
The "Harvard Nurses Study," officially titled Silicone Breast Implants and Connective Tissue Disease, was conducted by
researchers at Harvard Medical School, the Harvard School of Public Health, and Brigham and Women's Hospital in Boston.
The study, first presented at the October 1994 meeting of the American College of Rheumatology and published June 22, 1995
in The New England Journal of Medicine, claims that there is no association between silicone breast implants and connective
tissue disease.
This study is seriously flawed and raises serious ethical issues:
Two of the authors of the study, Dr. Graham A. Colditz and Dr. Matthew H. Liang, admitted under threat of perjury that
they were paid consultants of breast implant manufacturers.
Dr. Colditz admitted under oath that he knew Dow Corning had donated $5 million to Brigham Women's Hospital.
Inappropriate scientific methodology was used. The information was gathered from questionnaires and conclusions were
based on follow-up medical records. The women in the study were never examined by the researchers.
The number of women in the study was too small and the time period too short. Of the 87,501 women studied, only
1,183 women had breast implants. The study included women who had intact, as opposed to ruptured, implants, as well
as women who had had implants for as little as one month. By including women with such recent implants, the study
erroneously concluded that the women would not become sick. Experts have determined that the latency period for
connective-tissue disease is between 8 and 15 years after implantation.
Conclusions about silicone poisoning were based on "classic auto-immune diseases" and symptoms. But silicone poisoning
is a new disease, which does not show "classic" autoimmune symptoms.
The National Cancer Institute and the National Institute of Health held a symposium in March 1995 on "The Immunology
of Silicone," to discuss recent evidence of high cancer rates in women with silicone breast implants. Experts at the
symposium concluded that exposure to silicone mammary implants sets into motion significant and long-lasting diseases
with many immunopathic findings.
There is a demonstrated association between silicone from breast implants and connective tissue disease. The silicone
stimulates the immune system, causing the body to attack itself.
These diseases include lupus (persistent ulcerous lesions that spread over the skin); scleroderma (an autoimmune disease
causing hardening of blood vessels and connective tissue); Sjogren's disease (dryness in the eyes, mouth, nose, vagina);
neurological problems such as numbness or tingling in the joints; problems with vision and hearing; silicone poisoning can
also cause a fibrotic condition in the lungs which can lead to suffocation.
Even the authors of the Harvard study admitted, "...the study cannot be considered definitively negative" regarding the link
between silicone and connective-tissue diseases.
While the Harvard study claims to support the findings of a previous pro-breast implant report by the Mayo Clinic, the Harvard
study's flaws are similar to the flaws in the Mayo Clinic study which examined a small group of women in a single area of
Minnesota over a brief period of time, with no follow-up research performed. In addition,
The Mayo Clinic study was partially funded by the American Society of Plastic and Reconstructive Surgeons.
The authors of the Mayo Clinic study themselves admit: "...our study has several limitations...Our results, therefore, cannot
be considered definitive proof of the absence of an association between breast implants and connective-tissue disease."
(New England Journal of Medicine, 6/16/94)
Richard Alexander is a specialist in personal injury litigation with 30 years in-depth experience. Emphasizing working relationships with clients has led to an exceptional record of success. He has served as a member of the Board of Governors of The State Bar of California, President of the Santa Clara County Bar Association and the Board of Governors of Consumer Attorneys of California. He is a founding member of the National Association of Consumer Advocates, and heads Alexander Hawes, LLP.
Alexander Hawes, LLP is a California law firm that specializes in personal injury, wrongful death, and financial losses caused by negligence, defective products, toxic chemicals, corporate misconduct or insurance fraud on behalf of consumers, small investors, injured workers and small businesses. In addition to individual cases the firm prosecutes class actions for large groups of individuals who have suffered financial loss as a result of corporate fraud, defective consumer products, and environmental pollution. The firm holds Martindale-Hubbell's highest rating and is recognized in the List of Preeminent Law Firms in the U. S.